Please use this identifier to cite or link to this item:
|Title:||Promyelocytic leukemia protein is required for gain of function by mutant p53||Authors:||Haupt, S.
Di Agostino, S.
|Issue Date:||1-Jun-2009||Citation:||Haupt, S., Di Agostino, S., Mizrahi, I., Alsheich-Bartok, O., Voorhoeve, M., Damalas, A., Blandino, G., Haupt, Y. (2009-06-01). Promyelocytic leukemia protein is required for gain of function by mutant p53. Cancer Research 69 (11) : 4818-4826. ScholarBank@NUS Repository. https://doi.org/10.1158/0008-5472.CAN-08-4010||Abstract:||Mutations in the p53 tumor suppressor are the most common genetic events in human cancer. These mutations not only result in a loss of wild-type p53 activity, but can also lead to a gain of new oncogenic properties. Understanding how these gained functions are regulated is in its infancy. In this study, we show that the promyelocytic leukemia (PML) protein is an important regulator of mutant p53. We show that PML interacts with mutant p53. Importantly, PML enhances the transcriptional activity of mutant p53. Unexpectedly, PML is required for the proliferation and colony formation of cancer cells bearing mutant p53. Down-regulation of PML expression inhibits the growth of mutant p53-expressing cancer cells, predominantly by promoting cell cycle arrest. Our results suggest that the tumor suppression function of PML depends on the status of p53. In the context of mutant p53, PML enhances its cancer-promoting activities. ©2009 American Association for Cancer Research.||Source Title:||Cancer Research||URI:||http://scholarbank.nus.edu.sg/handle/10635/110613||ISSN:||00085472||DOI:||10.1158/0008-5472.CAN-08-4010|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on May 29, 2020
WEB OF SCIENCETM
checked on May 21, 2020
checked on May 23, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.